Additionally, the 36-month beta value for GKOS is 1.05. There are mixed opinions on the stock, with 8 analysts rating it as a “buy,” 3 rating it as “overweight,” 4 rating it as “hold,” and 1 rating it as “sell.”
The public float for GKOS is 53.13M and currently, short sellers hold a 4.84% ratio of that float. The average trading volume of GKOS on December 27, 2024 was 533.77K shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
GKOS) stock’s latest price update
The stock price of Glaukos Corporation (NYSE: GKOS) has dropped by -2.30 compared to previous close of 152.67. Despite this, the company has seen a gain of 3.77% in its stock price over the last five trading days. zacks.com reported 2024-12-24 that GKOS announces New Drug Application submission for its Epioxa to the FDA.
GKOS’s Market Performance
GKOS’s stock has risen by 3.77% in the past week, with a monthly rise of 5.99% and a quarterly rise of 16.27%. The volatility ratio for the week is 3.61% while the volatility levels for the last 30 days are 3.48% for Glaukos Corporation The simple moving average for the past 20 days is 4.24% for GKOS’s stock, with a 23.58% simple moving average for the past 200 days.
Analysts’ Opinion of GKOS
Many brokerage firms have already submitted their reports for GKOS stocks, with Citigroup repeating the rating for GKOS by listing it as a “Buy.” The predicted price for GKOS in the upcoming period, according to Citigroup is $162 based on the research report published on December 11, 2024 of the current year 2024.
UBS, on the other hand, stated in their research note that they expect to see GKOS reach a price target of $182. The rating they have provided for GKOS stocks is “Buy” according to the report published on December 06th, 2024.
Morgan Stanley gave a rating of “Underweight” to GKOS, setting the target price at $120 in the report published on December 02nd of the current year.
GKOS Trading at 6.91% from the 50-Day Moving Average
After a stumble in the market that brought GKOS to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -2.83% of loss for the given period.
Volatility was left at 3.48%, however, over the last 30 days, the volatility rate increased by 3.61%, as shares surge +5.07% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +16.94% upper at present.
During the last 5 trading sessions, GKOS rose by +4.30%, which changed the moving average for the period of 200-days by +71.12% in comparison to the 20-day moving average, which settled at $143.13. In addition, Glaukos Corporation saw 87.65% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at GKOS starting from Gilliam Joseph E, who sale 3,328 shares at the price of $149.85 back on Dec 20 ’24. After this action, Gilliam Joseph E now owns 102,169 shares of Glaukos Corporation, valued at $498,716 using the latest closing price.
Kliman Gilbert H, the Director of Glaukos Corporation, sale 10,000 shares at $150.28 during a trade that took place back on Dec 20 ’24, which means that Kliman Gilbert H is holding 32,336 shares at $1,502,800 based on the most recent closing price.
Stock Fundamentals for GKOS
Current profitability levels for the company are sitting at:
- -0.33 for the present operating margin
- 0.77 for the gross margin
The net margin for Glaukos Corporation stands at -0.42. The total capital return value is set at -0.14. Equity return is now at value -26.10, with -15.95 for asset returns.
Based on Glaukos Corporation (GKOS), the company’s capital structure generated 0.08 points at debt to capital in total, while cash flow to debt ratio is standing at -1.28. The debt to equity ratio resting at 0.08. The interest coverage ratio of the stock is -9.93.
Currently, EBITDA for the company is -82.12 million with net debt to EBITDA at -0.62. When we switch over and look at the enterprise to sales, we see a ratio of 23.13. The receivables turnover for the company is 6.39for trailing twelve months and the total asset turnover is 0.39. The liquidity ratio also appears to be rather interesting for investors as it stands at 5.54.
Conclusion
In conclusion, Glaukos Corporation (GKOS) has seen better performance in recent times. Analysts have a bullish opinion on the stock, with some rating it as a “buy” and others rating it as a “hold”. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
